You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

15-010

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Symbiofilm Trial in Allergic Kids (SYMBIOFILM-TAK)

Recruiting
  • Common Cold
  • Allergy
  • Healsea® Children
  • Conventional therapies for common cold
  • Białystok, Poland
  • +14 more
Mar 11, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Atlanta (VX15/2503, Ipilimumab, Nivolumab)

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • VX15/2503
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital Midtown
Mar 2, 2022

Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID

Recruiting
  • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
  • +2 more
  • Ipilimumab
  • +3 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Feb 11, 2022

Colon Carcinoma Metastatic in the Liver, Colorectal Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Atlanta, Rochester

Active, not recruiting
  • Colon Carcinoma Metastatic in the Liver
  • +13 more
  • Anti-SEMA4D Monoclonal Antibody VX15/2503
  • +3 more
  • Atlanta, Georgia
  • +3 more
Dec 15, 2021

Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Los Angeles, Salt Lake

Terminated
  • Metastatic Melanoma
  • +5 more
  • Anti-SEMA4D Monoclonal Antibody VX15/2503
  • +4 more
  • Los Angeles, California
  • +1 more
Apr 1, 2021

Non-Cystic Fibrosis Bronchiectasis Trial in Worldwide (Brensocatib 10 mg, Brensocatib 25 mg, Placebo)

Recruiting
  • Non-Cystic Fibrosis Bronchiectasis
  • Brensocatib 10 mg
  • +2 more
  • Birmingham, Alabama
  • +416 more
Jan 24, 2023

Asthma Trial in Worldwide (CHF 5259 12.5 µg, CHF 5259 )

Completed
  • Asthma
  • CHF 5259 12.5 µg
  • CHF 5259 placebo
  • Ruse, Bulgaria
  • +27 more
Apr 6, 2021

SARS-CoV-2 Infection, COVID-19 Trial in United Kingdom (SARS-CoV-2 rS/Matrix M1-Adjuvant, Placebo, Licensed seasonal influenza

Active, not recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • SARS-CoV-2 rS/Matrix M1-Adjuvant
  • +2 more
  • Belfast, Antrim, United Kingdom
  • +32 more
Oct 19, 2022

COPD Trial in Worldwide (Itepekimab (SAR440340), Placebo, Any Inhaled Corticosteroids as prescribed by treating physician as

Completed
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Los Angeles, California
  • +82 more
Oct 28, 2022

Classical Hodgkin Lymphoma Trial in Guangzhou (Zimberelimab 240mg)

Recruiting
  • Classical Hodgkin Lymphoma
  • Zimberelimab 240mg
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-Sen University Cancer Ce
Jun 15, 2023

CNS Lymphoma Trial in China (Selinexor, Rituximab, Methotrexate)

Not yet recruiting
  • Central Nervous System Lymphoma
  • Hefei, Anhui, China
  • +4 more
Jan 26, 2023

Hyperkalemia Trial in Worldwide (Patiromer, Placebos)

Completed
  • Hyperkalemia
  • Alexander City, Alabama
  • +414 more
Jan 11, 2022

Metastatic Solid Tumor Cancer Trial in Caen, Paris, Villejuif (Dose escalation, first-in-human phase I clinical trial with an

Recruiting
  • Metastatic Solid Tumor Cancer
  • Dose escalation, first-in-human phase I clinical trial with an Expansion phase
  • Caen, France
  • +2 more
Oct 11, 2022

Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in China (ATG-010 and ATG-008)

Recruiting
  • Relapsed/Refractory Diffuse Large B-cell Lymphoma
  • ATG-010 and ATG-008
  • Chongqing, Chongqing, China
  • +5 more
Sep 2, 2022

Idiopathic Hypersomnia, Excessive Daytime Sleepiness Trial in United States (pitolisant)

Enrolling by invitation
  • Idiopathic Hypersomnia
  • Excessive Daytime Sleepiness
  • Peoria, Arizona
  • +57 more
Nov 10, 2022

Retinitis Pigmentosa, Retinitis, Retinal Diseases Trial in Puerto Rico, United States (Gene Therapy Product-vMCO-010, Sham

Active, not recruiting
  • Retinitis Pigmentosa
  • +6 more
  • Gene Therapy Product-vMCO-010
  • Sham Injection
  • Beverly Hills, California
  • +6 more
Jul 13, 2022

Low Back Pain Trial in Worldwide (Matching Placebo, Low Dose GRT6005, Medium Dose GRT6005)

Completed
  • Low Back Pain
  • Matching Placebo
  • +4 more
  • Senftenberg, Austria
  • +78 more
Jul 13, 2021

Melanoma Trial in Nedlands, Haifa, Jerusalem (Pembrolizumab/Vibostolimab, Pembrolizumab)

Recruiting
  • Melanoma
  • Pembrolizumab/Vibostolimab
  • Pembrolizumab
  • Nedlands, Western Australia, Australia
  • +2 more
Jan 31, 2023

Asthma Trial in Worldwide (Placebo, Brodalumab)

Terminated
Has Results
  • Asthma
  • Placebo
  • Brodalumab
  • Birmingham, Alabama
  • +160 more
Feb 3, 2022

Haemophilus Influenzae Type b, Neisseria Meningitidis, Neisseria Meningitidis-Haemophilus Influenzae Type b Vaccine Trial in

Completed
Has Results
  • Haemophilus Influenzae Type b
  • +2 more
  • Menitorix
  • Infanrix IPV
  • Bydgoszcz, Poland
  • +8 more
Jun 2, 2020

Multiple Myeloma Trial in Guangzhou (Selinexor, Bortezomib, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Guangzhou, Guangdong, China
  • +3 more
Aug 16, 2022

Asthma Trial in Worldwide (QAX576, Placebo)

Completed
  • Asthma
  • QAX576
  • Placebo
  • Phoenix, Arizona
  • +51 more
Dec 11, 2020

Advanced NSCLC Trial in Shanghai (GLS-012+GLS-010, GLS-012+GLS-010+pemetrexed+carboplatin,

Not yet recruiting
  • Advanced Non-Small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shang Hai Pulmonary Hospital
Aug 3, 2023

Pancreatic Cancer Trial run by the (ipilimumab)

Completed
Has Results
  • Pancreatic Cancer
  • ipilimumab
  • Bethesda, Maryland
  • +1 more
Sep 24, 2021

Refractory Chronic Cough Trial in Worldwide (BLU-5937, Placebo)

Completed
  • Refractory Chronic Cough
  • Peoria, Arizona
  • +115 more
Dec 10, 2021